Context Lower urinary tract symptoms (LUTS) are common, often bothersome, and have
multifactorial aetiology. Objective To present a summary of the 2023 version of the European …

Lower urinary tract symptoms (LUTS) are highly prevalent among older men and have a
negative impact on health-related quality of life. Frequent comorbidity with potential prostatic …

Purpose: To revise the 2003 version of the American Urological Association's (AUA)
Guideline on the management of benign prostatic hyperplasia (BPH). Materials and …

ContextMen with overactive bladder and other lower urinary tract symptoms may not
respond to monotherapy with antimuscarinic agents or α-receptor antagonists. ObjectiveTo …

From time to time we publish a full review of drugs that are available for the treatment of
common conditions. In this issue, the review is written by two of the leading authorities in the …

The pharmacological treatment of urinary incontinence Page 1 BJU International (1999), 84,
923–947 REVIEW The pharmacological treatment of urinary incontinence K.-E …

Purpose: Antimuscarinic therapy for men with OAB and BOO is perceived as a potential risk
for urinary retention. Using pressure flow urodynamics, we evaluated the safety of …

In a study of patients with BOO and an overactive bladder, authors from Seoul and
Pittsburgh compared the use of doxazosin with or without tolterodine. The combination of the …

BACKGROUND: Some men receiving α-blocker therapy for lower urinary tract symptoms
report persistent storage symptoms suggestive of overactive bladder (OAB). OBJECTIVE: To …

The article reports on the clinical guideline for overactive bladder (OAB) published by the
Neurogenic Bladder Society. The guideline provides detailed explanation of the reasons for …